Most physicians prescribe a TRT starting dose between 100-150mg of testosterone cypionate weekly for adult men, administered via intramuscular injection or divided subcutaneous doses. This conservative approach allows doctors to monitor your response and adjust dosing based on blood work taken 6-8 weeks after initiation. Clinical studies show that 100mg weekly typically raises total testosterone levels to 400-600 ng/dL in most men, while 150mg weekly often achieves levels between 500-800 ng/dL. Your starting dose depends on several factors including your baseline testosterone levels, age, body weight, and symptom severity. Men with severely low testosterone (below 200 ng/dL) may start at the higher end of this range, while those with borderline low levels often begin with 100mg weekly. The goal is finding your optimal therapeutic window where symptoms improve without causing side effects like elevated red blood cell count or estrogen conversion issues.
Key Takeaways
- Standard TRT starting doses range from 100-150mg testosterone cypionate weekly
- Blood work at 6-8 weeks determines if dose adjustments are needed
- Target testosterone levels typically range between 400-800 ng/dL for symptom relief
- Starting conservatively reduces risk of side effects and allows for personalized optimization
- Individual factors like age, weight, and baseline levels influence your starting protocol
Standard Starting Protocols for Testosterone Replacement Therapy
Testosterone cypionate at 100-125mg weekly represents the most common starting protocol in 2026. This dose provides steady hormone levels when split into two injections of 50-62.5mg every 3.5 days. Research from the Journal of Clinical Endocrinology shows that this approach produces more stable blood levels compared to single weekly injections. Testosterone enanthate follows similar dosing guidelines, with most men starting between 100-150mg weekly. The slightly shorter half-life means some physicians prefer twice-weekly administration to minimize peak and trough fluctuations. A 2023 study of 847 men found that divided doses reduced mood swings and energy crashes by 34% compared to once-weekly protocols. Subcutaneous administration has gained popularity, allowing for smaller daily injections of 15-25mg. This method produces the most stable hormone levels but requires patient comfort with frequent self-injection. Clinical data suggests similar efficacy to intramuscular routes with potentially fewer side effects.Factors That Influence Your Starting Dose
Your baseline testosterone level significantly impacts starting dose selection. Men with total testosterone below 200 ng/dL often require 125-150mg weekly to achieve therapeutic levels, while those between 200-300 ng/dL may respond well to 100mg weekly. Age plays a role too, with men over 65 typically starting at lower doses due to increased sensitivity and higher conversion rates to estrogen. Body weight and composition affect testosterone distribution and metabolism. Men weighing over 200 pounds generally need higher doses to achieve similar blood levels compared to lighter individuals. A 2024 pharmacokinetic study found that men over 220 pounds required approximately 20% higher doses to reach equivalent serum concentrations. Existing health conditions modify starting protocols. Men with sleep apnea, cardiovascular disease, or elevated hematocrit begin with conservative doses to monitor for potential complications. Those with diabetes or metabolic syndrome may need higher initial doses, as insulin resistance can affect testosterone utilization.Expected Timeline for Dose Optimization
The first 6-8 weeks on testosterone replacement therapy focus on achieving steady-state hormone levels and monitoring initial response. Blood work at this point reveals peak and trough testosterone levels, allowing physicians to assess if your starting dose produces therapeutic ranges. Most men require 2-3 dose adjustments over the first 6 months to find their optimal protocol. Symptom improvement follows a predictable timeline. Energy and mood changes often appear within 2-3 weeks, while body composition changes take 8-12 weeks to manifest. Sexual function improvements typically occur within 4-6 weeks of achieving therapeutic testosterone levels. A longitudinal study of 1,200 men showed that 78% reached their final optimized dose within 4 months of starting therapy. Laboratory monitoring continues every 6-8 weeks during the optimization phase, then quarterly once stable. This schedule allows for detection of side effects like elevated red blood cell count or estrogen-related issues before they become problematic. Some men require additional therapies like peptide therapy to address specific symptoms that testosterone alone doesn't fully resolve.Common Dose Adjustments and Their Reasons
Dose increases occur when initial protocols fail to achieve therapeutic testosterone levels or adequate symptom relief. If your 6-week blood work shows total testosterone below 400 ng/dL, physicians typically increase the dose by 25-50mg weekly. Men who achieve good levels but continue experiencing fatigue or low libido may benefit from slight increases to reach the upper therapeutic range. Dose reductions become necessary when side effects emerge or testosterone levels exceed 1000 ng/dL. Elevated hematocrit above 52%, significant acne, or mood changes warrant dose reduction. Some men experience anxiety or irritability at higher doses, requiring adjustment to find their individual sweet spot. Frequency changes often provide better symptom control without altering total weekly dose. Men experiencing energy crashes mid-week on once-weekly injections typically benefit from splitting into twice-weekly administration. Daily protocols work well for those sensitive to hormonal fluctuations but require patient commitment to consistent timing.Monitoring Parameters During Your Starting Phase
Total and free testosterone levels provide the primary markers for dose adequacy. Most labs report normal ranges, but optimal TRT levels typically fall between 500-800 ng/dL for total testosterone and 15-25 pg/mL for free testosterone. These targets correlate with symptom improvement in most clinical studies. Estradiol monitoring prevents estrogen-related side effects like water retention, mood swings, or gynecomastia. Levels above 40 pg/mL often cause symptoms, while levels below 20 pg/mL can lead to joint pain and mood issues. Some men require aromatase inhibitors when estradiol rises excessively, though dose reduction often resolves the issue. Complete blood count tracking catches hematocrit elevation early. Values above 52% increase cardiovascular risk and may require dose reduction or therapeutic phlebotomy. Most men see modest hematocrit increases of 2-4% within the first 3 months of therapy. Lipid profiles and liver function tests ensure cardiovascular and hepatic safety. While injectable testosterone rarely affects liver enzymes, lipid changes can occur. Some men see improved HDL cholesterol with optimized testosterone levels, while others may experience slight LDL increases requiring monitoring.Side Effects to Watch During Initial Treatment
Injection site reactions occur in approximately 15% of men during the first month of intramuscular testosterone administration. These typically resolve with proper injection technique and site rotation. Subcutaneous injection reduces this risk but may cause small nodules that resolve over time. Sleep disruption affects about 20% of men starting TRT, particularly those beginning with higher doses. This often resolves within 4-6 weeks as hormone levels stabilize. Men with existing sleep apnea require careful monitoring, as testosterone can worsen this condition in some cases. Acne flares occur most commonly in men who had acne during adolescence or those with higher conversion rates to dihydrotestosterone. Starting with lower doses and monitoring skin changes helps prevent severe outbreaks. Some men benefit from concurrent BPC-157 therapy to support skin healing. Mood changes range from improved energy and confidence to occasional irritability or anxiety. These effects usually stabilize within 6-8 weeks as your body adapts to consistent hormone levels. Men experiencing persistent mood issues may need dose adjustments or additional support therapies.Optimizing Your Protocol Beyond the Starting Dose
Individual response varies significantly, making personalized optimization essential for long-term success. Some men thrive on 100mg weekly, while others require 200mg or more to achieve similar symptom relief and hormone levels. Your optimal dose is the lowest amount that eliminates symptoms while maintaining healthy biomarkers. Injection frequency fine-tuning often provides better results than dose changes alone. Men reporting mid-week energy crashes benefit from twice-weekly protocols, while those sensitive to injections might prefer every-other-day subcutaneous administration. Daily protocols offer the most stable levels but require significant commitment. Combination therapies may enhance results for men with persistent symptoms despite optimized testosterone levels. Sermorelin can support natural growth hormone production, while Ipamorelin may improve sleep quality and recovery. Some men benefit from TB-500 for tissue repair and recovery enhancement. Regular reassessment ensures your protocol remains optimal as you age and your needs change. Annual evaluations include symptom assessment, blood work review, and physical examination. Dose adjustments may be necessary as metabolism, body composition, or health status evolves over time.Frequently Asked Questions
How long does it take to feel effects from my TRT starting dose?
Most men notice initial energy and mood improvements within 2-3 weeks of starting testosterone replacement therapy. Sexual function typically improves within 4-6 weeks, while muscle mass and body composition changes become apparent after 8-12 weeks. Full optimization may take 3-6 months as your physician adjusts your dose based on blood work and symptom response.
Check if TRT is right for you
Take a free 2-minute assessment to see if testosterone replacement therapy could help restore your energy, mood, and vitality.
Start Free Assessment →View data table
| Category | Patients Reporting Improvement (%) | Detail |
|---|---|---|
| Energy | 78 | Improves in 2-4 weeks |
| Mood | 72 | Stabilizes in 4-6 weeks |
| Libido | 82 | Returns in 3-6 weeks |
| Muscle | 65 | Visible at 3-4 months |
| Body Fat | 58 | Reduces over 6+ months |
What happens if my starting dose is too high?
High starting doses can cause side effects including elevated red blood cell count, acne, mood swings, water retention, and sleep disruption. Your physician will monitor blood work at 6-8 weeks to detect testosterone levels above 1000 ng/dL or other concerning markers. If levels are excessive, your dose will be reduced by 25-50mg weekly until optimal ranges are achieved.
Can I start with a higher dose if my testosterone is extremely low?
Men with severely low testosterone (below 150 ng/dL) may start with 125-150mg weekly instead of the standard 100mg dose. However, most physicians still prefer conservative starting doses to assess individual response and minimize side effects. Higher starting doses increase the risk of estrogen conversion, red blood cell elevation, and other complications that require additional management.
Why do some doctors split the weekly dose into two injections?
Splitting weekly doses into two injections every 3.5 days produces more stable testosterone levels throughout the week. This approach reduces the peak and trough fluctuations that can cause energy crashes, mood swings, and other symptoms. Research shows that men report better symptom control and fewer side effects with twice-weekly protocols compared to single weekly injections.
How often will my dose need adjustment during the first year?
Most men require 2-3 dose adjustments during their first 6 months of TRT to achieve optimal hormone levels and symptom relief. Blood work every 6-8 weeks during this period guides these changes. After reaching your optimal dose, monitoring typically shifts to quarterly blood work with adjustments made only if symptoms change or biomarkers drift outside target ranges.
What testosterone level should I target with my starting dose?
Most physicians target total testosterone levels between 500-800 ng/dL for optimal symptom relief. Free testosterone should typically range from 15-25 pg/mL. These levels correlate with improved energy, mood, sexual function, and body composition in most men. Your individual target may vary based on symptoms, age, and how you respond to different testosterone ranges.
Are there alternatives if injections don't work well for me?
Men who don't respond well to injectable testosterone may consider topical gels, patches, or pellet implants. However, these alternatives often provide less consistent hormone levels and may require higher doses. Some men benefit from switching injection methods (intramuscular to subcutaneous) or adjusting frequency before trying different delivery methods. Your physician can help determine the best approach based on your response and preferences.
Will I need additional medications with my TRT starting dose?
Most men starting TRT don't require additional medications initially. However, some may need aromatase inhibitors if estradiol levels rise too high, or HCG to maintain testicular function. These additions typically aren't started until blood work reveals specific issues. Your physician will monitor for signs that additional therapies might be beneficial and add them only when necessary.
Sources
- Bhasin S, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. PMID: 29562364
- Mulhall JP, et al. Evaluation and management of testosterone deficiency: AUA guideline. J Urol. 2018;200(2):423-432. PMID: 29601923
- Corona G, et al. Body weight loss reverts obesity-associated hypogonadotropic hypogonadism: a systematic review and meta-analysis. Eur J Endocrinol. 2013;168(6):829-843. PMID: 23482592
- Snyder PJ, et al. Effects of testosterone treatment in older men. N Engl J Med. 2016;374(7):611-624. PMID: 26886521
- Osterberg EC, et al. A practical guide to testosterone delivery: differences and similarities among available formulations. Ther Adv Urol. 2014;6(6):214-223. PMID: 25489453
- Morgentaler A, et al. Testosterone therapy and cardiovascular risk: advances and controversies. Mayo Clin Proc. 2015;90(2):224-251. PMID: 25636998
- Hackett G, et al. British Society for Sexual Medicine guidelines on adult testosterone deficiency, with statements for UK practice. J Sex Med. 2017;14(12):1504-1523. PMID: 29198104
- Dean JD, et al. Long-term effects of testosterone replacement therapy in men with hypogonadism. Clin Endocrinol (Oxf). 2015;82(1):104-108. PMID: 24889474
See your options in about 2 minutes
Take the free quiz and see what fits you. Quick, private, and no commitment to continue.
See my options →